Literature DB >> 8699162

Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction.

I S Bevan1, C C Sammons, C Sweet.   

Abstract

Studies with 6 ts mutants of mouse cytomegalovirus indicated that mutants tsm1, tsm2, tsm3, and tsm6, like wild-type (wt) virus, produced acute infection in mice, became latent, and were reactivated as infectious virus immunosuppression. Using PCR, all five viruses expressed immediate-early (IE)-1, early (E)-1, and late (L, gB) genes during acute infection in all tissues examined (salivary glands, lung, spleen, liver, kidney, and heart). DNA was present in most tissues during latent infection with all five viruses, but transcription was restricted to the IE-1 gene in the salivary glands of wt infected mice only, suggesting true molecular latency rather than low level virus persistence. Similarly, mutant tsm5 expressed all three genes following primary inoculation. Although no detectable virus was produced, tsm5 subsequently entered the latent state as evidenced by DNA detection without RNA transcription indicating that productive infection is not required to initiate latency. This mutant also failed to reactivate from latency, although all three marker genes were expressed in most tissues. In contrast, tsm4 expressed all three marker genes and produced infectious virus during acute infection, then became latent. However, upon immunosuppression to reactivate tsm4, IE-1 and E-1 transcription occurred but neither gB transcription nor infectious virus was detectable in salivary glands, lung, spleen, liver, kidney, heart, or blood. The significance of this with regard to reactivation from latency is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699162     DOI: 10.1002/(SICI)1096-9071(199604)48:4<308::AID-JMV3>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.

Authors:  Charles H Cook; Joanne Trgovcich; Peter D Zimmerman; Yingxue Zhang; Daniel D Sedmak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.

Authors:  Jon D Reuter; Jean H Wilson; Kimberly E Idoko; Anthony N van den Pol
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).

Authors:  C S Morello; L D Cranmer; D H Spector
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection.

Authors:  Alice A Bickerstaff; Peter D Zimmerman; Bret A Wing; Frederick Taylor; Joanne Trgovcich; Charles H Cook
Journal:  J Virol Methods       Date:  2007-02-15       Impact factor: 2.014

6.  Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain.

Authors:  Jon D Reuter; Daniel L Gomez; Jean H Wilson; Anthony N Van Den Pol
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation.

Authors:  Christof K Seckert; Angélique Renzaho; Hanna-Mari Tervo; Claudia Krause; Petra Deegen; Birgit Kühnapfel; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

8.  Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.

Authors:  Steven R Wilson; Jean H Wilson; Linda Buonocore; Amy Palin; John K Rose; Jon D Reuter
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

9.  Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue.

Authors:  Lisa Kercher; Bradley M Mitchell
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.

Authors:  Mark Beswick; Annette Pachnio; Sarah N Lauder; Clive Sweet; Paul A Moss
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.